Protein-S Test at Ayzal Lab

Protein-S Test at Ayzal Lab

The Protein-S test is a specialized hematological laboratory investigation designed to measure the activity or concentration of Protein S in the blood. Protein S is a vitamin K-dependent plasma glycoprotein synthesized primarily in the liver and endothelial cells. It plays a critical role in the natural anticoagulant system of the human body. Specifically, Protein S acts as a non-enzymatic cofactor to activated Protein C (APC), which degrades clotting factors Va and VIIIa, thereby limiting the coagulation cascade and preventing excessive thrombus (blood clot) formation. Ayzal Lab, located in Lahore, Pakistan, offers this advanced diagnostic assay to assist in the evaluation of hypercoagulable states, also known as thrombophilia.

Understanding the physiological role of Protein S is essential for appreciating its diagnostic value. In the circulation, Protein S exists in two forms: free Protein S (approximately 40%) and bound Protein S (approximately 60%), which is complexed with C4b-binding protein (C4bBP). Only the free form of Protein S possesses active cofactor properties to assist activated Protein C. Consequently, clinical laboratories may measure free Protein S antigen, total Protein S antigen, or Protein S functional activity. At Ayzal Lab, our laboratory services utilize modern automated coagulometers and immunoturbidimetric assays to provide precise and reproducible measurements of these parameters, ensuring high clinical accuracy for patients presenting with thromboembolic complications.

The clinical importance of evaluating Protein S levels cannot be overstated. A deficiency in this protein, whether inherited or acquired, significantly increases a patient’s risk of developing deep vein thrombosis (DVT), pulmonary embolism (PE), and other venous thromboembolic events (VTE). Inherited Protein S deficiency is an autosomal dominant disorder that predisposes individuals to recurrent thrombosis. Acquired deficiencies are more common and can arise from various clinical conditions, including hepatic disease, vitamin K deficiency, oral anticoagulant therapy (such as warfarin), pregnancy, oral contraceptive use, and active inflammatory states. By determining the precise levels of Protein S, physicians can make informed decisions regarding long-term anticoagulation therapy, prophylactic measures during high-risk periods, and family screening protocols.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is vital to ensure the accuracy of the Protein-S test, as several physiological factors and medications can significantly alter the results. Patients undergoing this test at Ayzal Lab should adhere to the following preparation guidelines:

• Anticoagulant Therapy Discontinuation: The patient must not be on active oral anticoagulant therapy (such as warfarin or direct oral anticoagulants like rivaroxaban or apixaban) for at least 2 weeks prior to blood collection, as these medications alter Protein S levels. If heparin is being administered, the test should ideally be delayed until heparin therapy has ceased for at least 48 hours, or as directed by the prescribing physician.
• Fasting Requirements: While strict fasting is not always mandatory, a fasting period of 8 to 12 hours is highly recommended to minimize lipemia in the blood sample, which can interfere with optical detection methods used in coagulation analyzers.
• Timing Post-Thrombosis: The test should not be performed during an acute thrombotic event or immediately after one. Active clotting consumes coagulation factors and natural anticoagulants, leading to transiently low Protein S levels. It is clinically recommended to wait at least 6 to 12 weeks after an acute thrombotic episode before testing.
• Avoid Testing During Pregnancy: Protein S levels naturally decrease during pregnancy and the immediate postpartum period. Unless absolutely necessary, testing should be deferred until at least 6 weeks postpartum to establish a true baseline.
• Hydration: Patients are encouraged to drink adequate amounts of water before the test to ensure easy venous access and prevent hemoconcentration.

During the Procedure

The collection of a blood sample for a Protein-S test at Ayzal Lab follows strict clinical protocols to prevent pre-analytical errors that could compromise the integrity of the coagulation factors. The procedure is performed by an experienced phlebotomist and involves the following steps:

• Patient Identification and Positioning: The phlebotomist verifies the patient’s identity using multiple identifiers. The patient is comfortably seated, and the arm is positioned to access the antecubital fossa.
• Venipuncture Site Selection: A suitable vein, typically the median cubital vein, is selected. The area is thoroughly cleansed with an antiseptic solution (such as 70% isopropyl alcohol) and allowed to air dry.
• Sample Collection: A tourniquet is applied briefly to facilitate vein visualization, but it is released as soon as blood flow begins to prevent hemoconcentration and activation of clotting factors. The blood is drawn into a light blue-top tube containing 3.2% buffered sodium citrate as an anticoagulant. The ratio of blood to anticoagulant (9:1) is critical; therefore, the tube must be filled precisely to the indicated fill line.
• Mixing the Sample: Immediately after collection, the tube is gently inverted 3 to 4 times to ensure thorough mixing of the blood with the sodium citrate. Vigorous shaking is strictly avoided to prevent hemolysis and platelet activation.
• Post-Collection Care: Pressure is applied to the venipuncture site with a clean cotton swab, followed by the application of a bandage. The patient is advised to keep the arm extended for a few minutes.
• Processing: The citrated blood sample is promptly transported to the laboratory, where it undergoes double centrifugation to obtain platelet-poor plasma (platelet count < 10,000/µL), which is essential for accurate coagulation testing.

When is a Protein-S Test Performed?

Evaluation of Unexplained Deep Vein Thrombosis (DVT)

Physicians request a Protein-S test when a patient presents with unexplained or recurrent deep vein thrombosis, especially at a young age (under 50 years). DVT involves the formation of blood clots in the deep veins, most commonly in the lower extremities. Symptoms include unilateral leg swelling, warmth, erythema, and localized pain. Identifying a Protein S deficiency helps clinicians determine if an underlying genetic or acquired thrombophilia is responsible for the clot, guiding decisions on the duration and intensity of anticoagulant therapy.

Investigation of Pulmonary Embolism (PE)

A pulmonary embolism is a life-threatening condition that occurs when a blood clot travels from the deep veins to the lungs, obstructing the pulmonary arteries. Patients may present with sudden-onset dyspnea, pleuritic chest pain, tachypnea, and hemoptysis. When a PE occurs without clear provoking risk factors (such as major surgery or prolonged immobilization), a thrombophilia workup, including a Protein-S test, is indicated to evaluate the patient’s natural anticoagulant defenses and prevent future potentially fatal recurrences.

Thrombosis in Unusual Anatomical Sites

While most venous clots occur in the legs, thrombosis can sometimes develop in unusual locations, such as the cerebral venous sinuses, portal vein, mesenteric veins, or hepatic veins (Budd-Chiari syndrome). Clots in these atypical vascular beds strongly suggest an underlying hypercoagulable state. A Protein-S test is performed in these clinical scenarios to investigate systemic clotting abnormalities, enabling targeted medical management to prevent further organ damage or stroke.

Family Screening for Inherited Thrombophilia

If a patient is diagnosed with an inherited Protein S deficiency, physicians often recommend screening first-degree relatives, especially those with a personal history of thromboembolism or those planning major surgery, pregnancy, or oral contraceptive use. Identifying asymptomatic family members with Protein S deficiency allows healthcare providers to implement prophylactic strategies during high-risk periods, significantly reducing their lifetime risk of developing dangerous thrombotic complications.

Evaluation of Recurrent Pregnancy Loss

Protein S deficiency has been associated with adverse pregnancy outcomes, including recurrent miscarriage, late-term fetal loss, preeclampsia, and placental abruption. During pregnancy, a hypercoagulable state naturally develops, but a pre-existing Protein S deficiency can lead to microthrombi formation in the placental vasculature, compromising fetal blood supply. A Protein-S test, performed outside of pregnancy, helps identify women who may benefit from low-molecular-weight heparin (LMWH) therapy during future pregnancies to improve gestational outcomes.

What Does a Protein-S Test Detect?

The Protein-S test is highly sensitive to alterations in the coagulation system and can detect several clinically significant states, including:

• Congenital (inherited) Protein S deficiency Type I (reduced total and free antigen, reduced functional activity).
• Congenital Protein S deficiency Type II (normal total and free antigen, but reduced functional activity).
• Congenital Protein S deficiency Type III (normal total antigen, but reduced free antigen and functional activity).
• Acquired Protein S deficiency secondary to severe hepatic parenchymal disease (impaired synthesis).
• Acquired deficiency due to Vitamin K deficiency (impaired gamma-carboxylation of the protein).
• Depletion of Protein S during acute, extensive thrombotic events (consumption coagulopathy).
• Protein S reduction associated with Disseminated Intravascular Coagulation (DIC).
• Estrogen-induced reduction in free Protein S levels due to oral contraceptive use.
• Hormone replacement therapy (HRT) induced alterations in coagulation inhibitors.
• Physiological reduction of Protein S levels during normal pregnancy.
• Acquired deficiency associated with active systemic inflammatory diseases (due to elevated C4b-binding protein).
• Reduction of Protein S functional activity during active warfarin (oral anticoagulant) therapy.
• Protein S loss in urine associated with nephrotic syndrome.
• Decreased synthesis of coagulation inhibitors in neonates (physiological neonatal deficiency).
• Impaired anticoagulant pathway function in patients with severe active infections or sepsis.
• Elevated levels of Protein S (rarely clinically significant, but occasionally seen in acute phase reactions).
• Normal therapeutic response and baseline levels in patients post-anticoagulation therapy.

Turnaround Time and Report Access at Ayzal Lab

At Ayzal Lab, we understand that timely diagnostic results are crucial for effective clinical decision-making. The Protein-S test involves complex specialized methodology, including immunoturbidimetric or functional clotting assays, which require meticulous calibration and quality control. Typically, the test results are finalized and verified by our consultant pathologist within 24 to 48 hours of sample collection. Patients and referring physicians are notified via SMS once the report is ready. Reports can be easily accessed and downloaded online through the official Ayzal Lab web portal or mobile application, ensuring a seamless and convenient experience for our patients in Lahore.

Protein-S Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Free Protein S Antigen	60% – 140% (may vary slightly by age and sex)	< 60% (indicates Type I or Type III deficiency, pregnancy, or estrogen use)
Total Protein S Antigen	60% – 140%	< 60% (suggests Type I deficiency, liver disease, or vitamin K deficiency)
Protein S Functional Activity	60% – 140%	< 60% (indicates functional deficiency, seen in Type I, II, and III deficiencies)
C4b-Binding Protein (C4bBP)	Normal physiological levels	Elevated levels (leads to decreased free Protein S during active inflammation)
Ratio of Free to Total Protein S	Balanced physiological ratio	Decreased ratio (indicates selective reduction of active free Protein S)
Coagulation Status	Normal, balanced hemostasis	Hypercoagulable state (increased risk of venous thromboembolism)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Ayzal Lab for Protein-S Test?

• Experienced healthcare professionals: Our clinical laboratory is staffed by highly qualified pathologists and technologists specializing in hematology and coagulation.
• Patient-focused care: We prioritize patient comfort and convenience, offering a welcoming environment and professional phlebotomy services.
• Quality diagnostic services: Ayzal Lab adheres to strict internal and external quality control protocols to ensure the highest accuracy of test results.
• Professional reporting: Our reports are comprehensive, easy to read, and verified by consultant pathologists to assist your physician in accurate diagnosis.
• Modern diagnostic approach: We utilize advanced automated analyzers and standardized methodologies for specialized coagulation testing.
• Comfortable environment: Our collection centers in Lahore are designed to provide a clean, hygienic, and stress-free experience for all patients.
• Convenient location: Easily accessible facilities across Lahore make it simple for patients to visit for blood collection and consultation.
• Commitment to accurate diagnosis: We are dedicated to providing reliable, evidence-based diagnostic insights to support effective patient management and treatment.